Video Vox

Sebnem Kalemli-Ozcan 09 February 2021

COVID-19 pandemic had a devastating effect on both lives and livelihoods in 2020. The arrival of effective vaccines can be a major game changer. However, vaccines are in short supply as of early 2021 and most of them are reserved for the advanced economies. Sebnem Kalemli-Özcan and colleagues find that advanced economies will pay the price in damage to their own economic recoveries if they fail to help developing countries with their vaccination programmes. You can read the paper here: The Economic Case for Global Vaccinations: An Epidemiological Model with International Production Networks Cem Cakmakli, Selva Demiralp, Sebnem Kalemli-Ozcan, Sevcan Yesiltas, Muhammed Yildirim CEPR DP No. 15710 January 2021

Anna Scherbina 03 February 2021

Though COVID vaccines are finally available, the rate at which they are administered is slow, and in the meantime the pandemic continues to claim about as many lives every day as the 9/11 tragedy. Anna Scherbina (Brandeis University) talks to Tim Phillips about an estimate that with the promised rate of vaccinations, if no additional non-pharmaceutical interventions are implemented, 406 thousand additional lives will be lost and the future cost of the pandemic will reach $2.4 trillion, or 11% of GDP. Using a cost-benefit analysis, she finds that a lockdown would be indeed optimal and, depending on the assumptions, it should last between two and four weeks and will generate a net benefit of up to $1.2 trillion.

You can find Anna's paper, Could the United States benefit from a lockdown? A cost-benefit analysis, in CEPR's Covid Economics Issue 65: 20 January 2021

Viral Acharya 26 January 2021

Viral Acharya talks to Tim Phillips about estimating the value of a COVID-19 cure using the behaviour of stock prices and a novel vaccine progress indicator. The value of a cure is worth between 5% and 15% of wealth and rises substantially with uncertainty surrounding the frequency and duration of the pandemic.

You can read the Covid economics Paper discussed, here: Covid Economics 61: 1–72.

Stefanie J. Huber 19 January 2021

Can private expenditures recover once social distancing restrictions are lifted or will the COVID-19 crisis have a sustained impact on consumer confidence, preferences, and, hence, spending? Steffi Huber (University of Amsterdam) talks to Tim Phillips

You can download Steffi's paper for free from CEPR is issue 59 of Covid Economics Papers: 'Is COVID-19 a consumption game changer? Evidence from a large-scale multi-country survey' (Alexander Hodbod, Cars Hommes, Stefanie J. Huber and Isabelle Salle)

Difang Huang 06 January 2020

In his Covid Economics paper [Issue 59, Paper 4] , Difang Huang (Monash University) uses data from the United States to show that social distancing lowered the average daily infection cases by 12%, and provides evidence that the effects are heterogeneous in an individual's income, race, education, and political belief. Here he discusses these findings with CEPR's Tim Phillips. You can find his paper here:

In Tim Phillip's last interview of 2020 for CEPR, he joins CEPR President Beatrice Weder di Mauro and Charles Wyplosz, editor of CEPR's influential Covid Economics Paper series, to look back at what has been an extraordinary year, both for CEPR and for the world in general.

Humberto Laudares 15 December 2020

Humberto Laudares ( Graduate Institute & University of Geneva) reveals a positive & statistically significant relationship between deforestation & the transmission of COVID19 in indigenous communities in Brazil. With intensified Mining & Conflict contributing to the spread. Read the paper discussed in this video in Issue 53 of CEPR's Covid Economics Papers

Nicolas Duquette 10 December 2020

What kind of message is most effective when trying to persuade communities to support vaccination drives? Nicholas Duquette talks to Tim Phillips about the results of a survey experiment which reveal divergent responses between white non-Hispanic respondents and non-white or Hispanic respondents, depending on whether the message emphasises either the risks of the virus or the safety of vaccination, to the respondent personally or to others
You can read the Covid Economics paper which details Nic's work,  '“Heard” immunity: Messages emphasizing the safety of others increase intended uptake of a COVID-19 vaccine in some groups', here:

Sandy Tubeuf 02 December 2020

Once a safe COVID-19 vaccine will become available, there will not be enough supply of it to vaccinate the entire population. Policy makers at national and international level are currently developing vaccine prioritization strategies. However, it is important that these strategies have sufficient levels of public support. Sandy Tubeuf (UC Louvain) discusses her work on how people perceive priority cases for vaccination. Read the Covid Economics paper behind this discussion: Who should get it first? Public preferences for distributing a COVID-19 vaccine by Jeroen Luyten, Sandy Tubeuf , Roselinde Kessels 

Christoph Trebesch 26 November 2020

What are the political costs of mismanaging a Pandemic? Loose pandemic policies are politically costly - governments that placed more weight on health rather than short-term economic outcomes obtained higher approval. Cristoph Trebesch (Kiel Institute for the World Economy, CEPR) talks to Tim Phillips about the findings in his recent Covid Economics paper: Corona politics: The cost of mismanaging pandemics Helios Herrera, Maximilian Konradt, Guillermo Ordoñez and Christoph Trebesch, Covid Economics #50 



CEPR Policy Research